Compare HOUR & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOUR | CPIX |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.8M | 73.6M |
| IPO Year | 2021 | 2007 |
| Metric | HOUR | CPIX |
|---|---|---|
| Price | $1.98 | $3.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.7K | ★ 61.6K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 150.00 | 58.70 |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $142,440,236.00 | $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $36.40 | ★ N/A |
| Revenue Growth | 3.03 | ★ 16.75 |
| 52 Week Low | $1.10 | $1.85 |
| 52 Week High | $6.84 | $6.27 |
| Indicator | HOUR | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 60.78 | 44.32 |
| Support Level | $1.75 | $2.95 |
| Resistance Level | $2.08 | $3.69 |
| Average True Range (ATR) | 0.06 | 0.25 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 88.98 | 61.11 |
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.